Amedica Corporation (NASDAQ:AMDA) released its quarterly earnings results on Tuesday. The medical equipment provider reported ($0.93) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.94) by $0.01, Yahoo Finance reports. Amedica Corporation had a negative net margin of 87.49% and a negative return on equity of 77.67%. The business had revenue of $2.96 million for the quarter.

Amedica Corporation (NASDAQ:AMDA) opened at $3.91 on Wednesday. Amedica Corporation has a 1-year low of $2.95 and a 1-year high of $9.96.

A hedge fund recently raised its stake in Amedica Corporation stock. Vanguard Group Inc. grew its stake in Amedica Corporation (NASDAQ:AMDA) by 7.1% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 595,866 shares of the medical equipment provider’s stock after buying an additional 39,603 shares during the quarter. Vanguard Group Inc. owned 2.26% of Amedica Corporation worth $226,000 at the end of the most recent reporting period. Hedge funds and other institutional investors own 57.50% of the company’s stock.

AMDA has been the topic of several research analyst reports. ValuEngine upgraded shares of Amedica Corporation from a “sell” rating to a “hold” rating in a research report on Friday, November 10th. Maxim Group downgraded shares of Amedica Corporation from a “buy” rating to a “hold” rating in a report on Monday, September 25th.

TRADEMARK VIOLATION WARNING: “Amedica Corporation (AMDA) Releases Earnings Results, Beats Estimates By $0.01 EPS” was originally reported by American Banking News and is owned by of American Banking News. If you are reading this piece on another publication, it was illegally stolen and reposted in violation of U.S. & international copyright law. The correct version of this piece can be viewed at https://www.americanbankingnews.com/2017/11/21/amedica-corporation-amda-announces-earnings-results-misses-estimates-by-10-21-eps.html.

About Amedica Corporation

Amedica Corporation is a commercial biomaterial company. The Company is a vertically integrated silicon nitride orthopedic medical device manufacturer. It is focused on using its silicon nitride ceramic technology platform to develop, manufacture and sell a range of medical devices. It is also engaged in developing wear- and corrosion-resistant implant components for hip and knee arthroplasty.

Earnings History for Amedica Corporation (NASDAQ:AMDA)

Receive News & Ratings for Amedica Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedica Corporation and related companies with MarketBeat.com's FREE daily email newsletter.